Literature DB >> 24722876

Multi-analytical platform metabolomic approach to study miltefosine mechanism of action and resistance in Leishmania.

Gisele A B Canuto1, Emerson A Castilho-Martins, Marina F M Tavares, Luis Rivas, Coral Barbas, Ángeles López-Gonzálvez.   

Abstract

Miltefosine (MT) (hexadecylphosphocholine) was implemented to cope with resistance against antimonials, the classical treatment in Leishmaniasis. Given the scarcity of anti- Leishmania (L) drugs and the increasing appearance of resistance, there is an obvious need for understanding the mechanism of action and development of such resistance. Metabolomics is an increasingly popular tool in the life sciences due to it being a relatively fast and accurate technique that can be applied either with a particular focus or in a global manner to reveal new knowledge about biological systems. Three analytical platforms, gas chromatography (GC), liquid chromatography (LC) and capillary electrophoresis (CE) have been coupled to mass spectrometry (MS) to obtain a broad picture of metabolic changes in the parasite. Impairment of the polyamine metabolism from arginine (Arg) to trypanothione in susceptible parasites treated with MT was in some way expected, considering the reactive oxygen species (ROS) production described for MT. Importantly, in resistant parasites an increase in the levels of amino acids was the most outstanding feature, probably related to the adaptation of the resistant strain for its survival inside the parasitophorous vacuole.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24722876     DOI: 10.1007/s00216-014-7772-1

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  21 in total

1.  Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptations.

Authors:  Maya Berg; Raquel García-Hernández; Bart Cuypers; Manu Vanaerschot; José I Manzano; José A Poveda; José A Ferragut; Santiago Castanys; Jean-Claude Dujardin; Francisco Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

2.  Bestatin induces specific changes in Trypanosoma cruzi dipeptide pool.

Authors:  Andrea Trochine; Darren J Creek; Paula Faral-Tello; Michael P Barrett; Carlos Robello
Journal:  Antimicrob Agents Chemother       Date:  2015-02-23       Impact factor: 5.191

3.  New Insights into the Mechanism of Action of the Cyclopalladated Complex (CP2) in Leishmania: Calcium Dysregulation, Mitochondrial Dysfunction, and Cell Death.

Authors:  Angela M A Velásquez; Paula J Bartlett; Irwin A P Linares; Thais G Passalacqua; Daphne D L Teodoro; Kely B Imamura; Stela Virgilio; Luiz R O Tosi; Aline de Lima Leite; Marilia A R Buzalaf; Jecika M Velasques; Adelino V G Netto; Andrew P Thomas; Marcia A S Graminha
Journal:  Antimicrob Agents Chemother       Date:  2021-10-11       Impact factor: 5.938

4.  Genomic Appraisal of the Multifactorial Basis for In Vitro Acquisition of Miltefosine Resistance in Leishmania donovani.

Authors:  P Vacchina; B Norris-Mullins; M A Abengózar; C G Viamontes; J Sarro; M T Stephens; M E Pfrender; L Rivas; M A Morales
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

5.  Lipase Precursor-Like Protein Promotes Miltefosine Tolerance in Leishmania donovani by Enhancing Parasite Infectivity and Eliciting Anti-inflammatory Responses in Host Macrophages.

Authors:  Deepak Kumar Deep; Ruchi Singh; Arpita Kulshrestha; Saima Wajid; Poonam Salotra
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

6.  Molecular Basis of the Leishmanicidal Activity of the Antidepressant Sertraline as a Drug Repurposing Candidate.

Authors:  Marta L Lima; María A Abengózar; Montserrat Nácher-Vázquez; María P Martínez-Alcázar; Coral Barbas; Andre G Tempone; Ángeles López-Gonzálvez; Luis Rivas
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

7.  Leishmania parasitophorous vacuole membranes display phosphoinositides that create conditions for continuous Akt activation and a target for miltefosine in Leishmania infections.

Authors:  Naixin Zhang; Samiksha Prasad; Charles-Eugene Huyghues Despointes; Jeffrey Young; Peter E Kima
Journal:  Cell Microbiol       Date:  2018-07-31       Impact factor: 3.715

8.  Efficacy of topical Miltefosine formulations in an experimental model of cutaneous leishmaniasis.

Authors:  Ma Florencia Peralta; Nadina A Usseglio; Ma Estefanía Bracamonte; Ma Laura Guzmán; Ma Eugenia Olivera; J Diego Marco; Paola A Barroso; Dolores C Carrer
Journal:  Drug Deliv Transl Res       Date:  2021-01-27       Impact factor: 4.617

Review 9.  Drug resistance in eukaryotic microorganisms.

Authors:  Alan H Fairlamb; Neil A R Gow; Keith R Matthews; Andrew P Waters
Journal:  Nat Microbiol       Date:  2016-06-24       Impact factor: 17.745

10.  Fitness and Phenotypic Characterization of Miltefosine-Resistant Leishmania major.

Authors:  Kimbra G Turner; Paola Vacchina; Maricela Robles-Murguia; Mariha Wadsworth; Mary Ann McDowell; Miguel A Morales
Journal:  PLoS Negl Trop Dis       Date:  2015-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.